NCT03511339 is a NA clinical trial of TecTraum device in Mild Traumatic Brain Injury, sponsored by TecTraum Inc..

Who is sponsoring NCT03511339?

NCT03511339 is sponsored by TecTraum Inc..

What drugs are being tested in NCT03511339?

Interventions in NCT03511339: TecTraum device.

What condition does NCT03511339 study?

NCT03511339 studies Mild Traumatic Brain Injury.

Is NCT03511339 still recruiting?

NCT03511339 is currently completed. Last updated 3 May 2023.

Last reviewed 2023-05-03 · How we verify

NCT03511339

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pro-2-Cool Device Clinical Study

Completed NA Last updated 3 May 2023

What this trial tests

NA trial testing TecTraum device in Mild Traumatic Brain Injury in 174 participants. Completed in 29 May 2022.

Timeline

4 November 2017

Primary endpoint
27 April 2022

29 May 2022

Quick facts

Lead sponsor	TecTraum Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	174
Start date	4 November 2017
Primary completion	27 April 2022
Estimated completion	29 May 2022
Sites	5 locations across United States

Drugs / interventions tested

TecTraum device

Conditions studied

Mild Traumatic Brain Injury — all drugs for Mild Traumatic Brain Injury →

Sponsor

TecTraum Inc.

Who can join

Adults 12 to 21, any sex, with Mild Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being conducted to quantify the clinical safety and efficacy of head and neck cooling when applied up to 8 days after mild traumatic brain injury (mTBI) among adolescents participating in sporting activities.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reduced Concussion Symptom Burden in Early Adolescent Athletes Using a Head-Neck Cooling Device.
Smith MA, McNinch NL, Chaney D, Shauver L, et al · · 2024 · cited 4× · PMID 38180057 · DOI 10.1097/jsm.0000000000001198

Verify or expand the search:

Other recruiting trials for Mild Traumatic Brain Injury

Currently open trials in the same condition.

NCT07246993 — Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms · NA · recruiting
NCT07356167 — Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury · NA · recruiting
NCT07097792 — Concussion Recovery and Support Program · NA · recruiting
NCT06956417 — REhabilitation of MEMory Symptoms After BRain Concussion · NA · recruiting
NCT06217575 — Brain Research Assessing Impacts of Neurophysiological Processing Speed Training in Veterans · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03511339 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TecTraum Inc.
Last refreshed: 3 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03511339.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing